Views

While many of us hit the ‘pause’ button on our lives during the pandemic, the speed of change within the healthcare system accelerated at pace.

We’ve asked some of our experts to share insights on the challenges posed by rare diseases in healthcare, particularly in the wake of the ongoing COVID-19 pandemic. Each has given their own take based on their experience of working in the rare disease space, based on the impact on payers, pharmaceutical companies and, most importantly, patients.